📈 Markets & Finance
Live
Moderna Is Up 109% in 2026. Jim Cramer Just Called It 'Finally Investable Again.' Is the Stock a No-Brainer Buy on Its Recent Pullback?
Written by Adria Cimino for The Motley Fool -> Moderna is known as a coronavirus vaccine giant, but it's progressively becoming a multi-product company. The biotech has several exciting candidates i
Nasdaq News — 20 July 2026
Text:
6
0
0
Moderna is known as a coronavirus vaccine giant, but it's progressively becoming a multi-product company. The biotech has several exciting candidates
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
YPF executive buys $200,000 in shares at $46.26
📈 Markets & Finance
Indian Shares Open Flat, Tracking Mixed Global Market Cues
📈 Markets & Finance
Stock market today: S&P 500, Nasdaq, Dow futures fall as oil surges, Trump declares ceasefire 'over'
📈 Markets & Finance
The World Cup could make 2026 the 'summer of working from home,' says RTO guru Nicholas Bloom
📈 Markets & Finance
REMX hits rare oversold level at 29.98
📈 Markets & Finance
Weather Channel raises streaming price to $5 a month
